XML 138 R123.htm IDEA: XBRL DOCUMENT v3.10.0.1
Selected Quarterly Financial Data (Unaudited) - Selected Quarterly Financial Data (Detail) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Selected Quarterly Financial Information [Line Items]                      
Net revenues $ 4,559 $ 4,529 $ 4,701 $ 5,065 $ 5,398 $ 5,617 $ 5,720 $ 5,650 $ 18,854 $ 22,385 $ 21,903
Gross profit 1,971 1,977 2,033 2,315 2,444 2,599 2,802 2,770 8,296 10,615 11,653
Net income (loss) (3,243) (197) (166) 1,134 (11,730) 610 (5,970) 641 (2,472) (16,449) 311
Net income (loss) attributable to Teva (2,886) (208) (176) 1,120 (11,535) 595 (5,970) 645 (2,150) (16,265) 329
Net income (loss) attributable to ordinary shareholders $ (2,940) $ (273) $ (241) $ 1,055 $ (11,600) $ 530 $ (6,035) $ 580 $ (2,399) $ (16,525) $ 68
Earnings per share attributable to ordinary shareholders:                      
Basic $ (2.85) $ (0.27) $ (0.24) $ 1.04 $ (11.41) $ 0.52 $ (5.94) $ 0.57 $ (2.35) $ (16.26) $ 0.07
Diluted $ (2.85) $ (0.27) $ (0.24) $ 1.03 $ (11.41) $ 0.52 $ (5.94) $ 0.57 $ (2.35) $ (16.26) $ 0.07